Epidemiology of benign breast lumps, is it changing: a prospective study


  • Navin Kumar Department of Surgery, All India Institute of Medical Sciences Rishikesh, Uttarakhand, India http://orcid.org/0000-0002-3397-1386
  • Janardan Prasad Department of Surgery, Rajendra Institute of Medical Sciences Ranchi, Jharkhand, India




Benign breast disease, Fibroadenoma, Fibrocystic disease of breast, Phyllodes tumor


Background: There are wide range of benign breast diseases reported from India. Breast lumps are one of the commonest presentations. Although most of the breast lumps are benign but patient become anxious due to fear of malignancy. Due to this, there is an increase in the use of screening mammography and the fine needle aspiration cytology (FNAC) or core needle biopsy (CNB), most of which yield benign findings. This study is aimed to evaluate the incidence of different types of benign breast lumps in respect to age, size, side and site, relation with parity and use of oral contraceptive pills and analyses of this result in relation with the past and recent study on benign breast diseases.

Methods: This study was conducted at Rajendra Institute of Medical Sciences, Ranchi (India) over a period of one and half years. Inclusion criteria was the cases with palpable breast lumps which were reported benign on either FNAC or CNB and exclusion criteria was the cases with breast malignancy and inflammatory breast lumps.

Results: Most common benign breast lump (BBL) was fibroadenoma followed by fibrocystic disease of breast. Fibroadenoma was mainly presented with lump only whereas fibrocystic diseases of breast presented with lump and pain. Most of the BBL was found in nullipara and OCP non-users.

Conclusions: Epidemiology of BBL is still the same when analyzed with past and recent study on the benign breast diseases. Triple assessment remains the key in the evaluation of breast lumps.


Caleffi M, Filho DD, Borghetti K, Graudenz M, Littrup PJ, Freeman-Gibb LA et al. Cryoablation of benign breast tumours: evolution of technique and technology. Breast. 2004;13:397-407.

Murillo Ortiz B, Botello Hernandez D, Ramirez Mateos C, Reynaga Garcia FJ. Benign breast diseases: clinical, radiological and pathological correlation. Ginecol Obstet Mex. 2002;70:613-8.

Heuser L, Spratt JS, Polk HC Jr. Growth rates of primary breast cancers. Cancer. 1979;43:1888-94.

Russo J. Hormonal control of breast development. In: DeGroot LJ, Jameson JL, Burger H, eds. Endocrinology. Philadelphia: W.B. Saunders; 2001:2181-2188.

Ginger MR, Gonzalez-Rimbau MF, Gay JP, Rosen JM. Persistent changes in gene expression induced by estrogen and progesterone in the rat mammary gland. Mol Endocrinol. 2001;15:1993-2009.

Potten CS, Watson RJ, Williams GT, Tickle S, Roberts SA, Harris M, et al. The effect of age and menstrual cycle upon proliferative activity of the normal human breast. Bri J Canc. 1988 Aug;58(2):163.

Naveen N, Mukherjee V. A clinical study of benign breast disease in rural population. J Evol Med Dent Sci. 2013;2(30):5499-511.

Donegan WL, Spratt JS. Common benign conditions of the breast. Cancer of the Breast. 2002;5:67-110.

Shukla HS, Kumar S. Benign breast disorders in nonwestern populations : Part II- Benign breast disorders in India. World J Surg. 1989;13(6):746-9.

Rangabashyam, N, Gnanaprakasam D, Krishnaraj DB, Monohar V, Vijaylakshmi SR. Spectrum of benign breast lesions in Madras. Ind. J R Coll Surg, Edinb. 1983;28(6):369-73.

Houssami N, Cheung MN, Dixon JM. Fibroadenoma of the breast. Med J Aust. 2001;174:185-8.

Sangma MB, Panda K, Dasiah S. A clinico-pathological study on benign breast diseases. Journal of clinical and diagnostic research: JCDR. 2013 Mar;7(3):503.

Kumar M, Ray K, Harode S, Wagh DD. The pattern of benign breast diseases in rural hospital in India. East Central Afri J Surg. 2010;15(2):59-64.

Kumar B, Khandelwal N, Paliwal AK, Ghosh M. Clinico- radiological -pathological study of benign breast diseases. Int J Cont Med Resea. 2018;5(12):L1-L4.

Akhator A. Benign breast masses in Nigeria. Nig J Surgi Scienc. 2007;17(2):105-8.

Mallikarjuna, Maralihalli SS. Clinico- pathological study of benign breast disease. Ind J Bas Appli Med Resea. 2015;4:39-46.

Carbonaro A, Ciotta L, Stracquadanio M, Formuso C, Giunta MR, Agati AD, et al. Oral contraception and benign breast diseases. Amer J Nur Scie. 2012;1(1):1-4.

Nomura A, Comstock GW, Tonascia JA. Epidemiologic characteristics of benign breast disease. Am J Epidemiol. 1977;105:505-12.

Kelsey JL, Lindfors KK, White C. A case-control study of the epidemiology of benign breast diseases with reference to oral contraceptive use. Int J Epidemiol. 1974;3:333-40.

Sartwell PE, Arthes FG, Tonascia JA. Epidemiology of benign breast lesions: lack of association with oral contraceptive use. N Engl J Med. 1973;288:551-4.

Khanna S, Aryya NC, Khanna NN. Spectrum of benign breast disease. Ind J Surg. 1988;50:169.

Sartwell PE, Arthes FG, Tonascia JA. Benign and malignant breast tumours: epidemiological similarities. Int J Epidemiol. 1978;7:217-21.






Original Research Articles